Osteoporosis as a potential contributor to the bone metastases

Medical Hypotheses

Volumn 75, Issue 6, 2010, Pages 514-516

  Wu, Yong Ping ^a   Chen, Wei Shan ^a   Xu, Sheng Jie ^b   Zhang, Ning ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; LEPTIN; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; BLOOD VESSEL; BONE MARROW; BONE METASTASIS; CANCER CELL; CANCER GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHESIS; INFLAMMATION; OSTEOLYSIS; OSTEOPOROSIS; PROTEIN EXPRESSION; RISK FACTOR; TUMOR MICROENVIRONMENT;

BONE NEOPLASMS; HUMANS; LEPTIN; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOPOROSIS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77958496165     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2010.07.010     Document Type: Article

References (25)

1. Nielsen O.S., Munro A.J., Tannock I.F. Bone metastases: pathophysiology and management policy. J Clin Oncol 1991, 9(3):509-524.
2. Leber M.F., Efferth T. Molecular principles of cancer invasion and metastasis (review). Int J Oncol 2009, 34(4):881-895.
3. Braun S., Vogl F.D., Naume B., et al. A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 2005, 353(8):793-802.
4. Lipton A., Brown G.A., Mundy G.R., Roodman G.D., Smith M.R. New opportunities for the management of cancer-related bone complications. Clin Adv Hematol Oncol 2009, 7(5 Suppl. 11):1-30.
5. Nannuru K.C., Futakuchi M., Varney M.L., Vincent T.M., Marcusson E.G., Singh R.K. Matrix metalloproteinase (MMP)-13 regulates mammary tumor-induced osteolysis by activating MMP9 and transforming growth factor-beta signaling at the tumor-bone interface. Cancer Res 2010, 70(9):3494-3504.
6. Min Y., Ren X., Vaught D.B., Chen J., Donnelly E., Lynch C.C., et al. Tie2 signaling regulates osteoclastogenesis and osteolytic bone invasion of breast cancer. Cancer Res 2010, 70(7):2819-2828.
7. Rove K.O., Crawford E.D. Metastatic cancer in solid tumors and clinical outcome: skeletal-related events. Oncology (Williston Park) 2009, 23(14 Suppl. 5):21-27.
8. Harvey N., Dennison E., Cooper C. Osteoporosis: impact on health and economics. Nat Rev Rheumatol 2010, 6(2):99-105.
9. Thanapprapasr D., Nartthanarung A., Likittanasombut P., et al. Bone metastasis in cervical cancer patients over a 10-year period. Int J Gynecol Cancer 2010, 20(3):373-378.
10. Arguello F., Baggs R.B., Frantz C.N. A murine model of experimental metastasis to bone and bone marrow. Cancer Res 1988, 48(23):6876-6881.
11. Khan M.N., Khan A.A. Cancer treatment-related bone loss: a review and synthesis of the literature. Curr Oncol 2008, 15(Suppl. 1):S30-S 40.
12. Gupta G.P., Massagué J. Cancer metastasis: building a framework. Cell 2006, 127(4):679-695.
13. Griffith J.F., Yeung D.K., Antonio G.E., et al. Vertebral bone mineral density, marrow perfusion, and fat content in healthy men and men with osteoporosis: dynamic contrast-enhanced MR imaging and MR spectroscopy. Radiology 2005, 236(3):945-951.
14. Reid I.R. Relationships between fat and bone. Osteoporos Int 2008, 19(5):595-606.
15. Steppan C.M., Crawford D.T., Chidsey-Frink K.L., Ke H., Swick A.G. Leptin is a potent stimulator of bone growth in ob/ob mice. Regul Pept 2000, 92(1-3):73-78.
16. Cinti S., Frederich R.C., Zingaretti M.C., De Matteis R., Flier J.S., Lowell B.B. Immunohistochemical localization of leptin and uncoupling protein in white and brown adipose tissue. Endocrinology 1997, 138(2):797-804.
17. Suganami T., Ogawa Y. Adipose tissue macrophages: their role in adipose tissue remodeling. J Leukoc Biol 2010, 88(1):33-39.
18. Weisberg S.P., McCann D., Desai M., Rosenbaum M., Leibel R.L., Ferrante A.W. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003, 112(12):1796-1808.
19. Holloway W.R., Collier F.M., Aitken C.J., et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002, 17(2):200-209.
20. Sierra-Honigmann M.R., Nath A.K., Murakami C., et al. Biological action of leptin as an angiogenic factor. Science 1998, 281(5383):1683-1686.
21. Thomas T. Leptin: a potential mediator for protective effects of fat mass on bone tissue. Joint Bone Spine 2003, 70(1):18-21.
22. Heida N.M., Leifheit-Nestler M., Schroeter M.R., et al. Leptin enhances the potency of circulating angiogenic cells via src kinase and integrin (alpha)vbeta5: implications for angiogenesis in human obesity. Arterioscler Thromb Vasc Biol 2010, 30(2):200-206.
23. Ellenrieder V., Buck A., Gress T.M. TGFbeta-regulated transcriptional mechanisms in cancer. Int J Gastrointest Cancer 2002, 31(1-3):61-69.
24. Kozlow W., Guise T.A. Breast cancer metastasis to bone: mechanisms of osteolysis and implications for therapy. J Mammary Gland Biol Neoplasia 2005, 10(2):169-180.
25. Dincer M., Bulut N., Harputluoglu H., Altundag K. Statins may decrease skeletal-related events in breast cancer patients with bone metastases. Med Hypotheses 2006, 67(5):1146-1147.